The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Axonal Regeneration into Acellular Nerve Grafts Is Enhanced by Degradation of Chondroitin Sulfate Proteoglycan
Open accessAbstract
Although the peripheral nerve has the potential to regenerate after injury, degenerative processes may be essential to promote axonal growth into the denervated nerve. One hypothesis is that the nerve contains growth inhibitors that must be neutralized after injury for optimal regeneration. In the present study, we tested whether degradation of chondroitin sulfate proteoglycan, a known inhibitor of axon growth, enhances the growth-promoting properties of grafts prepared from normal donor nerves. Excised segments of rat sciatic nerve were made acellular by freeze-killing before treatment with chondroitinase ABC. Chondroitinase-dependent neoepitope immunolabeling showed that chondroitin sulfate proteoglycan was thoroughly degraded throughout the treated nerve segments. In addition, neuronal cryoculture assays revealed that the neurite-promoting activity of acellular nerves was significantly increased by chondroitinase treatment. Control and chondroitinase-treated acellular nerves were then used as interpositional grafts in a rat nerve injury model. Axonal regeneration into the grafts was assessed 4 and 8 d after implantation by growth-associated protein-43 immunolabeling. At both time points, the number of axons regenerating into acellular grafts treated with chondroitinase was severalfold greater than in control grafts. Growth into the chondroitinase-treated grafts was pronounced after only 4 d, suggesting that the delay of axonal growth normally associated with acellular grafts was attenuated as well. These findings indicate that chondroitinase treatment significantly enhanced the growth-promoting properties of freeze-killed donor nerve grafts. Combined with the low immunogenicity of acellular grafts, the ability to improve axonal penetration into interpositional grafts by preoperative treatment with chondroitinase may be a significant advancement for clinical nerve allografting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zuo, J., Ferguson, T. A., Hernandez, Y. J., Stetler-Stevenson, W. G., & Muir, D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05203.1998 · Cited by 270
Self-citation
Cited by
Gu, X., Ding, F., Yang, Y., & Liu, J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.11.002 · Cited by 583
Repairing injured peripheral nerves: Bridging the gap
Deumens, R., Bozkurt, A., Meek, M. F., Marcus, M. A. E., Joosten, E. A. J., Weis, J., & Brook, G. A. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.002 · Cited by 510
Specificity of peripheral nerve regeneration: Interactions at the axon level
Allodi, I., Udina, E., & Navarro, X. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.005 · Cited by 420
Processed allografts and type I collagen conduits for repair of peripheral nerve gaps
Whitlock, E. L., Tuffaha, S. H., Luciano, J. P., Yan, Y., Hunter, D. A., Magill, C. K., Moore, A. M., Tong, A. Y., Mackinnon, S. E., & Borschel, G. H. (2009) · Muscle & Nerve · doi:10.1002/mus.21220 · Cited by 406
Biomaterials for the Development of Peripheral Nerve Guidance Conduits
Nectow, A. R., Marra, K. G., & Kaplan, D. L. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0240 · Cited by 395
Metadata
- Authors
- Krekoski, C. A., Neubauer, D., Zuo, J., & Muir, D.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-08-15
- Volume
- 21
- Issue
- 16
- Pages
- 6206-6213
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2165475742
- Cited by
- 179
- References
- 1
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Axonal Regeneration into Acellular Nerve Grafts Is Enhanced by Degradation of Chondroitin Sulfate Proteoglycan. https://app.cochat.ai/papers/10.1523/jneurosci.21-16-06206.2001
- The paper
- Krekoski, C. A., Neubauer, D., Zuo, J., & Muir, D. (2001). Axonal Regeneration into Acellular Nerve Grafts Is Enhanced by Degradation of Chondroitin Sulfate Proteoglycan. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.21-16-06206.2001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.